Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease–related Interstitial Lung Diseases

REFERENCES

1. 1.↵
   1. Steen VD,
   2. Medsger TA

   . Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 2007;66:940–4.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Tyndall AJ,
   2. Bannert B,
   3. Vonk M,
   4. Airò P,
   5. Cozzi F,
   6. Carreira PE,
   7. et al.

   Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809–15.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Olson AL,
   2. Swigris JJ,
   3. Sprunger DB,
   4. Fischer A,
   5. Fernandez-Perez ER,
   6. Solomon J,
   7. et al.

   Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 2011;183:372–8.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Komocsi A,
   2. Vorobcsuk A,
   3. Faludi R,
   4. Pintér T,
   5. Lenkey Z,
   6. Költo G,
   7. et al.

   The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology 2012;51:1027–36.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Saketkoo LA,
   2. Matteson EL,
   3. Brown KK,
   4. Seibold JR,
   5. Strand V

   . Developing disease activity and response criteria in connective tissue disease related interstitial lung disease. J Rheumatol 2011;38:1514–8.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Swigris JJ,
   2. Stewert AL,
   3. Gould MK,
   4. Wilson SR

   . Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 2005;3:61.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Boers M,
   2. Brooks P,
   3. Strand V,
   4. Tugwell P

   . The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198–9.

   OpenUrlPubMed